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Abstract
The hallmark of endochondral bone development is the presence of cartilaginous templates, in 
which osteoblasts and stromal cells are generated to form mineralized matrix and support bone 
marrow hematopoiesis. However, the ultimate source of these mesenchymal cells and the 
relationship between bone progenitors in fetal life and those in later life are unknown. Fate-
mapping studies revealed that cells expressing cre-recombinases driven by the collagen II (Col2) 
promoter/enhancer and their descendants contributed to, in addition to chondrocytes, early 
perichondrial precursors prior to Runx2 expression and, subsequently, to a majority of osteoblasts, 
Cxcl12 (chemokine (C-X-C motif) ligand 12)-abundant stromal cells and bone marrow stromal/
mesenchymal progenitor cells in postnatal life. Lineage-tracing experiments using a tamoxifen-
inducible creER system further revealed that early postnatal cells marked by Col2-creER, as well 
as Sox9-creER and aggrecan (Acan)-creER, progressively contributed to multiple mesenchymal 
lineages and continued to provide descendants for over a year. These cells are distinct from adult 
mesenchymal progenitors and thus provide opportunities for regulating the explosive growth that 
occurs uniquely in growing mammals.
Introduction
Most bones are formed through endochondral bone development, in which mesenchymal 
condensations first define the domain for the future bones, and then develop into the growth 
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cartilage wherein chondrocytes appear and proliferate. Chondrocytes in the growth plate 
continue to proliferate well into adulthood in mice1. In the center of the developing cartilage 
mold, chondrocytes stop proliferating and become hypertrophic chondrocytes. These cells 
signal to induce the migration of mesenchymal cells into the marrow space; these cells then 
differentiate into osteoblasts that then form bone on top of the cartilaginous matrix. 
Perichondrial precursors expressing osterix (Osx) invade into the cartilage template along 
with blood vessels and eventually become both osteoblasts and stromal cells in the marrow 
space2. However, mesenchymal cells constituting earlier cells of the osteoblast lineage than 
Osx+ precursors in vivo have not been fully characterized. The transcription factor Sox9 is 
expressed in mesenchymal condensations, and osteochondroprogenitors are derived from 
Sox9+ cells, as Sox9-cre marks all chondrocytes and osteoblasts3. Sox9 binds to genes 
encoding major cartilaginous matrix proteins such as aggrecan (Acan) and type II collagen-
α1 (Col2a1) and regulates their expression. How these early osteochondroprogenitors and 
their descendants relate to mesenchymal precursors in adult bone is unknown. In adult 
endochondral bones, the source of osteoblasts and stromal cells has been proposed to be 
mesenchymal stem cells (MSCs) or bone marrow stromal/mesenchymal progenitor cells 
(BMSCs), which are traditionally defined as cells capable of forming colonies in vitro 
(CFU-Fs: colony forming unit-fibroblasts) that can undergo multilineage differentiation in 
vitro and upon transplantation4. CFU-Fs are enriched among various adult marrow 
populations such as nestin (Nes)-GFP+ cells5, platelet-derived growth factor receptor-α 
(PDGFRα)+Sca1+CD45−Ter119− (PαS) cells6 and leptin receptor (LepR)/LepR-cre+ cells7 
in mice and CD146+ pericytes in humans8. In this study, we sought to identify cells that 
robustly supply osteoblasts and stromal cells in the metaphyses of growing bones, and 
suggest the possibility that these cells might be the source of MSCs/BMSCs in adult bone 
marrow.
Results
Col2-cre/Col2-creER are expressed in early cells of the osteoblast lineage in fetal mice
We chose to explore the hypothesis that cells defined by activities of the Sox9, aggrecan 
(Acan), and type II collagen (Col2) gene promoter/enhancers might encompass 
mesenchymal precursors of osteoblasts and stromal cells. Previous studies indicate that 
osteochondroprogenitors are marked by cre recombinases driven by the Col2a1 
promoter9–12. First, we mapped cell fates using a Col2-cre; R26R-tdTomato reporter13, 14 in 
combination with Col1(2.3kb)-GFP15 as a readout of osteoblastic cells. In this system, cells 
expressing Col2-cre and their descendants become red, and if they concurrently express 
Col1-GFP, they become yellow. In addition, a thymidine analog, EdU, was administered 
shortly before analysis to evaluate cell proliferation. At embryonic day 12.5 (E12.5), red 
cells were observed in the growth cartilage (Figure 1a, asterisks) and perichondrium (Figure 
1a, sharps), where many of these cells were proliferating (See also Supplementary Figure 1a 
for an earlier day). At E14.5, almost all Col1-GFP+ cells appearing in the osteogenic 
perichondrium were yellow (Figure 1b, arrowheads); thus, these perichondrial preosteoblasts 
were derived from Col2-cre+ cells. Active cell proliferation was observed in the 
perichondrium, but not in its adjacent hypertrophic chondrocytes (Figure 1b). At E15.5, 
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Col2-cre-derived cells proliferated within the marrow space, as the nascent primary 
ossification center was occupied by red cells (Figure 1c, asterisks).
Second, we mapped cell fates using an Osx-cre∷GFP; R26R-tdTomato reporter16. In this 
system, cells expressing Osx-cre∷GFP become green in the nucleus, and these cells and 
their descendants become red. At E12.5, Osx+ yellow cells (expressing Osx-cre∷GFP and 
tdTomato) were observed in the growth cartilage and perichondrium, in a domain more 
restricted than that of Col2-cre targeted cells (Figure 1d, arrows). At E14.5, Osx+ yellow 
cells dominated the inner part of the perichondrium in a domain broader than Col1+ cells 
seen in Fig.1b (Figure 1e, arrows), with some of them in proliferation (Supplementary 
Figure 1f,g). Osx+ prehypertrophic chondrocytes appearing green were not proliferating 
(Figure 1e, arrowheads). At E15.5, mesenchymal cells appearing in the primary ossification 
center were largely yellow (Figure 1f, asterisks), and therefore expressing Osx. These 
comparative fate mapping analyses suggest that one fate of Col2+ cells may be to become 
Osx+ cells in the perichondrium and the marrow space.
Runx2 is a crucial transcription factor in osteoblastic differentiation genetically upstream of 
Osx17. To understand whether Col2+ cells require Runx2 expression, as, for example, 
nestin-GFP+ perichondrial cells do18, we analyzed mice carrying Runx2-null alleles19 in 
addition to the Col2-cre; R26R-tomato; Col1-GFP transgenes. In these mice, no Col1-GFP+ 
cell appeared in the perichondrium at E14.5. However, despite the absence of Runx2, Col2-
cre-derived red cells were still present in the perichondrium (Figure 1g, arrows) and its 
underlying growth cartilage (Figure 1g, right panel, arrowheads). Therefore, Runx2 is 
dispensable for generating these Col2-cre-derived progenitor cells, although it is required 
for their further differentiation into osteoblasts. This places Col2+ cells in the perichondrium 
upstream of Runx2 expression in the lineage.
We next examined the distribution of Col2-cre targeted red cells at postnatal day 3 (P3), 
when bone marrow hematopoiesis had been established. Col2-cre targeted red cells 
contributed not only to chondrocytes and perichondrial cells in the growth cartilage, but also 
to Col1-GFP+ osteoblasts, osteocytes and Cxcl12high stromal cells20, 21 in the marrow space 
(Figure 1h,i, see also Supplementary Figure 1b,c). Osx-cre targeted red cells contributed to 
all these cell types22, 23 (Figure 1j,k, see also Supplementary Figure 1d,e). Flow cytometry 
analysis of dissociated bone cells revealed that Osx-cre targeted cells contributed to 
essentially all osteoblasts (95.5±0.7% of Col1-GFPhigh and 97.8±1.3% of Oc-GFPhigh15) 
and Cxcl12-expressing stromal cells (92.1±6.9% of Cxcl12-GFPhigh, n=3 per group, data 
represented as mean ± SD) 24 (Figure 1m). Col2-cre targeted cells also contributed to a great 
majority of osteoblasts (80.0±2.8% of Col1-GFP+ and 78.1±5.9% of Oc-GFP+) and Cxcl12-
expressing stromal cells (89.6±5.2% of Cxcl12-GFPhigh, n=3 per group, data represented as 
mean ± SD) (Figure 1l). Therefore, most osteoblasts and Cxcl12-expressing stromal cells in 
endochondral bones are derived from mesenchymal progenitors/precursors that express 
Col2-cre and Osx-cre at some point in their development.
To further clarify the relationships between Col2+ cells and Osx+ cells within the 
mesenchymal lineage, we took advantage of tamoxifen-inducible creER recombinases 
(Col2-creER25 or Osx-creER2) and performed pulse-chase experiments with a single 
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tamoxifen injection. An E11.5 pulse to Col2-creER mice marked perichondrial cells and 
chondrocytes at E12.5 (Figure 2a), and their descendants (Col2creER-E11.5) contributed to 
the perichondrium and the primary ossification center at E15.5 (Figure 2b) and yielded a 
number of Tomato+ cells throughout the bone at P0 (Figure 2c) and P21 (Supplementary 
Figure 2a). In contrast, an E11.5 pulse to Osx-creER mice did not give rise to descendants at 
P0 (Figure 2d), suggesting that Col2-creER+ cells appeared earlier than Osx-creER+ cells 
during early skeletal development. An E13.5 pulse to Col2-creER mice marked 
chondrocytes beneath the perichondrium, as well as perichondrial cells, at E14.5 (Figure 2e), 
and their descendants (Col2creER-E13.5) contributed to the primary ossification center at 
E16.5 (Figure 2f). Col2creER-E13.5 cells continued to yield Tomato+ cells robustly in the 
growth cartilage, the perichondrium and the bone at P0 (Figure 2g) and including the 
secondary ossification center in the epiphyseal region at P21 (Figure 2h). Osx-creER+ cells 
at E13.5 proliferate in the primary ossification center at E16.52 but do not persist in the 
perichondrium18. Their descendants (OsxcreER-E13.5) appeared as osteoblasts and stromal 
cells among cells derived from the primary ossification center, but not those of the 
secondary ossification center at P0 (Figure 2i), and then gradually disappeared from the 
metaphysis by P21 (Figure 2j and Supplementary Figure 2b). These data underscore the 
transient nature of embryonic Osx-creER+ cells, supporting the notion that these cells are 
replenished by their precursors, probably derived from Col2-creER cells during early bone 
development.
Col2-creER-expressing cells at an early postnatal stage generate multiple mesenchymal 
lineages
Because cells expressing Col2-creER in fetal life appear to be early cells in the osteoblast 
lineage, we next asked whether this transgene is also active in postnatal life. For this 
purpose, Col2-creER; R26R-tomato25 mice were pulsed with a low-dose tamoxifen injection 
at P3. A small number of Tomato+ cells were detected at P5 and P10 in the absence of 
tamoxifen administration (Supplementary Figure 2d,e). Two days after a tamoxifen pulse at 
P3 (Col2creER-P3), chondrocytes in the growth plate and beneath the perichondrium, as well 
as cells in the perichondrium and metaphyseal spongiosa, were labeled by Col2-creER 
(Figure 4a). After a week, a group of Col2creER-P3 cells appeared directly under the growth 
plate in the primary spongiosa and beneath the unlabeled cells of the perichondrium with 
further contiguity to the endocortical surface (Figure 3a, arrowheads, see also Figure 4b). 
After a month, Col2creER-P3 cells became osteoblasts and stromal cells in the metaphysis 
and epiphysis, in addition to chondrocytes in the growth plate and articular cartilage (Figure 
3b, see also Figure 4e). During an extended chase period over a year after the pulse, 
Col2creER-P3 cells continued to yield chondrocytes, osteoblasts and stromal cells in the 
metaphysis, and also became adipocytes in the metaphyseal bone marrow (Figure 3c,d and 
Supplementary Figure 2f). Of note, Col2-creER does not mark marrow cells in the middle of 
the diaphysis at P3, even though Col2-cre marks all stromal and osteoblastic regions of 
bone. Presumably, this contrast results from the Col2 promoter driving the expression of 
creER no longer being active in marrow stromal cells in the diaphysis at P3.
The contrast between the cells marked by Col2-creER and Osx-creER transgenes is 
instructive. Shortly after the pulse, a majority of osteoblasts on the bone surface and cells in 
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the perichondrium were marked by Osx-creER (Figure 4c). After a week of chase, OsxcreER-
P3 cells continued to be present on the bone surface and in the marrow space (Figure 3e, see 
also Figure 4d). After a month, OsxcreER-P3 cells became osteoblasts and stromal cell in the 
metaphysis and diaphysis, but not in the epiphysis (Figure 3f, see also Figure 4f). In contrast 
to the persistence of Col2creER-P3 cells in the one year chase, OsxcreER-P3 cells gradually 
disappeared from the metaphysis and became increasingly present as stromal cells in the 
diaphyseal bone marrow and osteoblasts on the endocortical surface (Figure 3g,h,m and 
Supplementary Figure 2c). The Osx-creER; R26R-tomato system had little to no tamoxifen-
independent activities (Figure 3k,l). Thus, Osx-creER+ cells at P3 generate cells in the 
metaphysis only transiently, but persist in the marrow stroma for a prolonged period.
To assess quantitatively how cells marked by Col2-creER or Osx-creER contribute 
differentially to defined cell types over time, we performed flow cytometry analysis of cells 
isolated from enzymatically-digested bones from triple transgenic mice (Col1-GFP or 
Cxcl12-GFP, Col2-creER or Osx-creER and R26R-tomato) with a single tamoxifen injection 
at P3. Shortly after the pulse, only a small fraction of cells marked by Col2-creER expressed 
these GFP reporters (48 hours after tamoxifen injection, Col1-GFP+; 3.2±1.2% [n=4], 
Cxcl12-GFPhigh, 0.3±0.1% [n=3], data represented as mean ± SD), suggesting that Col2-
creER+ cells were largely distinct from osteoblasts or Cxcl12-expressing stromal cells 
(Figure 4g, left panels). The fraction of Col2creER-P3 cells among osteoblasts and Cxcl12-
expressing stromal cells increased progressively as the chase period extended (Col1-GFP+; 
from 8.7±2.1% [n=3], 23.7±1.7% [n=5], 27.6±1.7% [n=3] to 29.3±4.6% [n=6], Cxcl12-
GFPhigh; from 1.9±0.3% [n=4], 7.3±3.1% [n=4], 9.9±1.2% [n=4] to 13.8±0.5% [n=4], for 
the first, second, third and fourth week, respectively, Figure 4g, middle panels, and Figure 
4i, blue and red lines, data represented as mean ± SD). No increase of Tomato+ cells was 
observed without tamoxifen injection (Figure 4g, right panels). In contrast, 87.9±1.4% [n=4] 
and 11.6±3.5% [n=3] of cells marked by Osx-creER shortly after the pulse were Col1-GFP+ 
osteoblasts and Cxcl12-expressing stromal cells, respectively, (Figure 4h, left panels, data 
represented as mean ± SD). The fraction of OsxcreER-P3 cells decreased among osteoblasts 
(58.1±10.9% [n=7] and 14.9±0.1% [n=3] for the first and fourth week, respectively, Figure 
4h, upper middle panel, and Figure 4j, blue line), and increased among Cxcl12-expressing 
stromal cells (49.2±6.3% [n=3] and 32.9±1.1% [n=4] for the second and fourth week, 
respectively, Figure 4h, lower middle panel, and Figure 4j, red line, data represented as 
mean ± SD). These studies reinforce the results from the histological findings that Col2-
creER-marked cells robustly contribute to osteoblasts and stromal cells, while Osx-creER-
marked cells transiently become osteoblasts and persist longer in bone marrow as stromal 
cells.
Relationship of growth skeletal progenitor cells and adult bone marrow stromal/
mesenchymal progenitor cells
In order to determine the relationship of the growth skeletal stem/progenitor cells that we 
have defined here with the more traditionally defined BMSCs, we conducted colony-
forming unit fibroblast (CFU-F) assays using unfractionated bone marrow cells isolated 
from P5 mice. Quantification of Tomato+ colonies revealed that Col2-cre targeted a higher 
proportion of CFU-Fs than Osx-cre did (Tomato+ CFU-F: Col2-cre; 42.9±6.3%, Osx-cre; 
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12.0±4.0%, Figure 5a,b, see also Supplementary Figure 3a, n=4 per group, data represented 
as mean ± SD), indicating that a larger fraction of BMSCs were derived from Col2-cre+ 
cells than from Osx-cre+ cell during development. To understand if BMSCs themselves 
express Col2 or Osx, CFU-F assays were performed using bone marrow cells harvested from 
Col2-creER or Osx-creER; R26R-tomato mice 2 days after the pulse. Only a small 
proportion of CFU-Fs were Tomato+ using this protocol (Tomato+ CFU-F: Col2-creER; 
1.9±1.7%, Osx-creER; 3.0±3.5%, Figure 5c, see also Supplementary Figure 3b, n=4 per 
group, data represented as mean ± SD), suggesting that the majority of BMSCs were rather 
descendants of cells expressing Col2-cre. Second, we conducted flow cytometry analysis of 
a PαS fraction using dissociated bone cells harvested from these mice at P5 (Supplementary 
Figure 3c). A PαS fraction represents <1% of the CD45−Ter119− fraction and is enriched for 
CFU-Fs6. Col2-cre targeted a higher proportion of PαS cells than Osx-cre did (Tomato+ 
PαS cells: Col2-cre; 44.0±6.9%, Osx-cre; 15.6±6.9%, Figure 5d,e, n=4 per group, data 
represented as mean ± SD), as anticipated from the fraction of CFU-Fs marked by these cre 
lines. A fraction of PαS cells was Cxcl12-GFPhigh, and a small percentage of Cxcl12-
GFPhigh cells was positive for Sca1; these fractions appeared to decrease with age 
(Supplementary Figure 3d,e). A great portion of Cxcl12-GFPhigh cells was PDGFRα+Sca1− 
cells (Supplementary Figure 3f). Nes-GFP+ cells include all CFU-Fs5 and are descended 
from Col2-creER+ cells during bone development18. Analysis of Nes-GFP; Col2-cre; R26R-
tomato bone cells revealed that 46.7±5.1% of Nes-GFP+ cells were targeted by Col2-cre 
(Supplementary Figure 4a, n=5, data represented as mean ± SD). We further interrogated the 
PαS fraction using Nes-GFP; Nes-creER; R26R-tomato mice and a single tamoxifen 
injection at P3. A high fraction of PαS cells was marked by Nes-creER and their 
descendants throughout the entire first month of chase (48 hours after the pulse, 41.6±17.8% 
[n=5], then 50.4±12.4% [n=3] and 44.9±2.8% [n=4] for the second and fourth week of 
chase, respectively, Fig.3f,g, data represented as mean ± SD). Nes-creER-marked cells 
contributed to Cxcl12-GFPhigh cells transiently (50.1±4.2% [n=3], 11.6±2.3% [n=4] then 
6.0±0.8% [n=3], for the second day, the first and fourth week of chase, respectively, data 
represented as mean ± SD, Supplementary Figure 4c), while their contribution to endothelial 
cells is predominant and persistent18. Virtually no PαS cell was marked by Col2-creER or 
Osx-creER shortly after the pulse (0.3±0.4% [n=4] and 0.7±0.3% [n=6], respectively, Figure 
5f,g, data represented as mean ± SD). During the chase, the fraction of PαS cells derived 
from OsxcreER-P3 cells gradually increased (5.2±2.6% [n=5] and 10.5±6.0% [n=8] for the 
second and fourth week, respectively), while those derived from Col2creER-P3 cells only 
temporarily increased (0.4±0.3% [n=5], 5.3±2.8% [n=7], 1.3±1.6% [n=5] and 1.4±1.3% 
[n=9] for the first to fourth week, respectively, data represented as mean ± SD) (Figure 
5f,g). Similarly, an E13.5 pulse to Col2-creER mice marked virtually no PαS after two 
weeks of chase at P7 (Supplementary Figure 4b). Therefore, while postnatal Col2-creER+ 
cells robustly contributed to Col1-GFP+ osteoblasts and Cxcl12high stromal cells during 
bone growth, their contribution to a PαS fraction appears to be minimal. Since Col2-cre+ 
cells do contribute substantially to the PαS population, it is possible that they do so at a time 
that we have not tested with Col2-creER mice. A PDGFRα+Sca1− fraction encompasses 
most BMSCs7. Col2-cre and Osx-cre also targeted a similar proportion of PDGFRα+Sca1− 
cells (Tomato+ PDGFRα+Sca1− cells: Col2-cre; 57.7±14.6%, Osx-cre; 57.2±5.7%, Figure 
5h,i, n=4 per group, data represented as mean ± SD). A sizable fraction of PDGFRα+Sca1− 
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cells were marked by Col2-creER or Osx-creER shortly after the pulse (16.1±5.8% [n=4] 
and 34.1±10.0% [n=6], respectively), while only marginally marked by Nes-creER 
(1.8±1.3% [n=5], Figure 5j,k, data represented as mean ± SD).
We asked further whether cells defined by promoter/enhancer activities of other genes 
involved in early chondrocyte development could, like Col2-creER, be used to mark early 
cells of the osteoblast lineage in postnatal bone development. For this purpose, we took 
advantage of Sox9-creER26 and aggrecan (Acan)-creER27 knock-in alleles and performed 
similar pulse-chase experiments. Shortly after the chase, Sox9-creER marked populations 
comparable to those marked by Col2-creER (Supplementary Figure 5a), while Acan-creER 
marked a larger number of perichondrial cells (Supplementary Figure 5c). After a week of 
chase, both Sox9creER-P3 and AcancreER-P3 cells increased in the metaphyseal spongiosa 
and endocortical surface (Figure 6a,b, see also Supplementary Figure 5b,d). We further 
conducted flow cytometry analysis using mice carrying Col1-GFP, Sox9-creER or Acan-
creER and R26R-tomato reporter. A small fraction of cells expressed Col1-GFP shortly after 
the pulse (Sox9-creER; 3.6±0.8%, Acan-creER; 5.0±2.1%, n=3 per group, data represented 
as mean ± SD), and the fraction among osteoblasts increased to 55.1±8.2% (Sox9-creER, 
n=8) and 65.9±8.2% (Acan-creER, n=5, data represented as mean ± SD) after 4 weeks of 
chase (Figure 6i,j). Both Sox9creER-P3 and AcancreER-P3 cells continued to generate 
osteoblasts and stromal cells at least for 6 months in a pattern that resembled those of 
Col2creER-P3 cells (Figure 6c,f). Little to no tamoxifen-independent activities was noted 
with the use of these knock-in lines (Figure 6g,h).
Discussion
Our data collectively indicated that cells defined by promoter/enhancer activities of genes 
associated with chondrocytes and their precursors, such as Sox9, Col2 and Acan encompass 
early mesenchymal progenitors that continue to become chondrocytes, osteoblasts, stromal 
cells and adipocytes during endochondral bone development. Cre/creER-recombinases 
driven by the Osx promoter mark a downstream population with limited lineage potential to 
generate osteoblasts and stromal cells (Supplementary Figure 6, see the diagram). Cells 
marked by Osx-creER at P3 are not continually generated in the metaphysis, in contrast to 
cells marked by Sox9-creER, Col2-creER and Acan-creER, but do persist as stromal cells in 
metaphyseal bone marrow. Any inconsistency of our data with Mizoguchi et al28 is likely 
due to the length of the chase, because we chased these cells for a longer period of time, for 
up to 18 months. In addition, when postnatal Col2-creER+ cells generated osteoblasts and 
stromal cells progressively in the metaphysis, there was no comparable increase of Col2-
creER+ descendants among a PαS fraction. We speculate that this latter observation may be 
relevant to findings recently published by Zhou et al7. These investigators found that, in 
adult mice, PαS cells overlapped considerably with those marked by leptin receptor (LepR)-
cre and that cells marked with the LepR-cre; R26R-tomato progressively marked 
osteoblasts, but only starting at two months of age. We suggest that the growth-associated 
progenitors that we have identified here may be the source of osteoblasts during the rapid 
phase of bone growth before LepR-cre-marked cells provide precursors for the osteoblast 
lineage. The demonstration of Col2-cre; R26R-tomato mice mark a large fraction of adult 
osteoblasts and stromal cells, including PαS cells, suggests that the adult mesenchymal 
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precursor cells might derive from the progenitors that we have identified. Transition of these 
growth-associated progenitors into adult BMSCs appears to be infrequent and requires 
continuous inputs to make an easily discernable contribution. Further experiments will be 
required to establish the relationship between the growth-related mesenchymal progenitors 
identified here and adult mesenchymal precursors. The existence of these two populations 
provides opportunities for distinct regulation of the explosive growth of bone in early life 
and the much slower remodeling that occurs in adulthood.
Methods
Mice
Col1(2.3kb)-GFP15, Oc-GFP15, Nestin-GFP29, Cxcl12-GFP/null20, Col2a1-cre13, Osx-
cre∷GFP16, Col2a1-creERT225, Osx-creERT22, Nestin-creERT230, Sox9-creERT226, Acan-
creERT227, Runx2-LacZ/null19 mice have been described elsewhere. Rosa26-loxP-stop-
loxP-tdTomato (R26R-tomato, JAX7914) mice were acquired from Jackson laboratory. All 
procedures were conducted in compliance with the Guideline for the Care and Use of 
Laboratory Animals approved by Massachusetts General Hospital’s Institutional Animal 
Care and Use Committee (IACUC). All mice were housed in a specific pathogen-free 
condition, and analyzed in a mixed background. Mice were identified by micro-tattooing or 
ear tags. Tail biopsies of mice were lysed by a HotShot protocol (incubating the tail sample 
at 95C° for 30 minutes in an alkaline lysis reagent followed by neutralization) and used for 
PCR-based genotyping (GoTaq Green Master Mix, Promega, and C1000 Touch Cycler, Bio-
rad). Perinatal mice were also genotyped fluorescently (BLS miner’s lamp) whenever 
possible. Mice were sacrificed by over-dosage of carbon dioxide or decapitation under 
inhalation anesthesia in a drop jar (Aerrane isoflurane, Henry Schein).
For experiments in Figure 1a–f, male mice (Col1-GFP; Col2-cre; R26RtdTomato/tdTomato or 
Osx-cre∷GFP; R26RtdTomato/tdTomato mice) were mated to female CD1 mice (>8 weeks old, 
Charles River Laboratories) and the vaginal plug was checked in the morning. For cell 
proliferation assay, 1mg of 5-ethynyl-2’-deoxyuridine (EdU) (Invitrogen A10044) dissolved 
in PBS was administered to pregnant mice three hours before sacrificed at indicated 
embryonic days. Embryos were used for analysis regardless of the sex. At least three 
embryos of the indicated genotype were examined at each time point shown in the figure.
For experiments in Figure 1g, male mice (Col1-GFP; Col2-cre; R26RtdTomato/tdTomato; 
Runx2+/−) were mated to female Runx2+/− mice. Embryos were used for analysis regardless 
of the sex. At least three embryos of the indicated genotype were examined at the time point 
shown in the figure.
For experiments in Figure 1h–m, male mice (Col1-GFP; Col2-cre; R26RtdTomato/tdTomato or 
Oc-GFP; Col2-cre; R26RtdTomato/tdTomato or Cxcl12-GFP; Col2-cre; R26RtdTomato/tdTomato 
or Col1-GFP; Osx-cre∷GFP; R26RtdTomato/tdTomato or Oc-GFP; Osx-cre∷GFP; 
R26RtdTomato/tdTomato or Cxcl12-GFP; Osx-cre∷GFP; R26RtdTomato/tdTomato) were mated to 
female CD1 mice. Pups at postnatal day 3 were used for analysis regardless of the sex. 
Three pups of the indicated genotype were examined at the time point shown in the figure. 
n=3 mice per group.
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For experiments in Figure 2, male mice (Col1-GFP; Col2-creER; R26RtdTomato/tdTomato or 
Col2-creER; R26RtdTomato/tdTomato or Osx-creER; R26RtdTomato/tdTomato) were mated to 
female CD1 mice and the vaginal plug was checked in the morning. Pregnant mice received 
1mg tamoxifen (Sigma T5648) and progesterone (Sigma P3972) intraperitoneally at an 
indicated embryonic day. Embryos or pups were used for analysis regardless of the sex. At 
least three embryos or pups of the indicated genotype were examined at the time point 
shown in the figure.
For experiments in Figure 3 and Figure 4, male mice (Col2-creER; R26RtdTomato/tdTomato or 
Col1-GFP; Col2-creER; R26RtdTomato/tdTomato or Cxcl12-GFP; Col2-creER; 
R26RtdTomato/tdTomato or Osx-creER; R26RtdTomato/tdTomato or Col1-GFP; Osx-creER; 
R26RtdTomato/tdTomato or Cxcl12-GFP; Osx-creER; R26RtdTomato/tdTomato) were mated to 
female FVB/N mice (Charles River Laboratories) to generate pups. Three day-old mice 
received 0.1mg of tamoxifen intraperitoneally using a method reported previously31. Mice 
were used for analysis regardless of the sex. At least three mice of the indicated genotype 
were examined at the time point shown in the figure. For no tamoxifen controls, the same 
amount of sunflower oil (without tamoxifen) was injected into three day-old mice. For 
experiments shown in Figure 4i and 4j, the number of mice used to plot the data was as 
following: Col1-GFP; Col2-creER; R26RTomato; n=4 (2 days chase), n=3 (1 week chase), 
n=5 (2 weeks chase), n=3 (3 weeks chase) and n=6 (4 weeks chase) mice; Cxcl12-GFP; 
Col2-creER; R26RTomato; n=3 (2 days chase), n=4 (1 week chase), n=4 (2 weeks chase), n=4 
(3 weeks chase) and n=4 (4 weeks chase) mice; Col1-GFP; Osx-creER; R26RTomato; n=4 (2 
days chase), n=7 (1 week chase) and n=3 (4 weeks chase) mice; Cxcl12-GFP; Osx-creER; 
R26RTomato; n=3 (2 days chase), n=3 (2 weeks chase) and n=4 (4 weeks chase) mice.
For experiments in Figure 5a,b, male mice (Col2-cre; R26RtdTomato/tdTomato or Osx-
cre∷GFP; R26RtdTomato/tdTomato) were mated to female FVB/N mice to generate pups. Mice 
were used for analysis regardless of the sex. Four mice of the indicated genotype were 
examined.
For experiments in Figure 5c, male mice (Col2-creER; R26RtdTomato/tdTomato or Osx-creER; 
R26RtdTomato/tdTomato) were mated to female FVB/N mice to generate pups. Three day-old 
mice received 0.1mg of tamoxifen intraperitoneally. Mice were used for analysis regardless 
of the sex. Four mice of the indicated genotype were examined.
For experiments in Figure 5d,e,h,i male mice (Cxcl12-GFP; Col2-cre; R26RtdTomato/tdTomato 
or Cxcl12-GFP; Osx-cre∷GFP; R26RtdTomato/tdTomato) were mated to female FVB/N mice 
to generate mice. Mice were used for analysis regardless of the sex. Four mice of the 
indicated genotype were examined.
For experiments in Figure 5f,g,j,k, male mice (Nes-GFP; Nes-creER; R26RtdTomato/tdTomato 
or Cxcl12-GFP; Col2-creER; R26RtdTomato/tdTomato or Cxcl12-GFP; Osx-creER; 
R26RtdTomato/tdTomato) were mated to female FVB/N mice to generate pups. Three day-old 
mice received 0.1mg of tamoxifen intraperitoneally. Mice were used for analysis regardless 
of the sex. For experiments shown in Figure 5g,k, the number of mice used to plot the data 
was as following: Nes-creER; R26RTomato; n=5 (2 days chase), n=3 (2 weeks chase) and n=4 
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(4 weeks chase) mice; Col2-creER; R26RTomato; n=4 (2 days chase), n=5 (1 week chase), 
n=7 (2 weeks chase), n=5 (3 weeks chase) and n=9 (4 weeks chase) mice; Osx-creER; 
R26RTomato; n=6 (2 days chase), n=5 (2 weeks chase) and n=8 (4 weeks chase) mice.
For experiments in Figure 6, male mice (Sox9-creER; R26RtdTomato/tdTomato or Col1-GFP; 
Sox9-creER; R26RtdTomato/tdTomato or Acan-creER; R26RtdTomato/tdTomato or Col1-GFP; 
Acan-creER; R26RtdTomato/tdTomato) were mated to female FVB/N mice to generate pups. 
Three day-old mice received 0.1mg of tamoxifen intraperitoneally. Mice were used for 
analysis regardless of the sex. At least three mice of the indicated genotype were examined 
at the time point shown in the figure. For no tamoxifen controls, the same amount of 
sunflower oil (without tamoxifen) was injected into three day-old mice. For experiments 
shown in Figure 6j, the number of mice used to plot the data was as following: Sox9-creER; 
R26RTomato; n=3 (2 days chase) and n=8 (4 weeks chase) mice; Col2-creER; R26RTomato; 
n=4 (2 days chase) and n=5 (4 weeks chase) mice; Acan-creER; R26RTomato; n=3 (2 days 
chase) and n=5 (4 weeks chase) mice.
For experiments in Supplementary Figure 4a, male mice (Nes-GFP; Col2-cre; 
R26RtdTomato/tdTomato) were mated to female FVB/N mice to generate pups. Mice were used 
for analysis regardless of the sex. Five mice of the indicated genotype were examined.
For experiments in Supplementary Figure 4b, male mice (Cxcl12-GFP; Col2-creER; 
R26RtdTomato/tdTomato) were mated to female CD1 mice and the vaginal plug was checked in 
the morning. Pregnant mice received 1mg tamoxifen and progesterone intraperitoneally at 
E13.5. Pups were used for analysis regardless of the sex. One pup of the indicated genotype 
was examined at P7.
For experiments in Supplementary Figure 4c, male mice (Cxcl12-GFP; Nes-creER; 
R26RtdTomato/tdTomato) were mated to female FVB/N mice to generate pups. Three day-old 
mice received 0.1mg of tamoxifen intraperitoneally. Mice were used for analysis regardless 
of the sex. At least three mice of the indicated genotype were examined at the time point 
shown in the figure.
Tamoxifen
Tamoxifen (Sigma T5648) was mixed with 100% ethanol until completely dissolved. 
Subsequently, a proper volume of sunflower seed oil (Sigma S5007) was added to the 
tamoxifen-ethanol mixture and rigorously mixed. The tamoxifen-ethanol-oil mixture was 
incubated at 60C° in a chemical hood until ethanol evaporated completely. The tamoxifen-
oil mixture was stored at room temperature until use.
Histology
Samples were dissected under a stereomicroscope (Nikon SMZ-10A) to remove soft tissues, 
and fixed in 4% paraformaldehyde, overnight at 4C°, then decalcified in 15% EDTA for a 
proper period, typically ranging from 1 to 14 days. Decalcified samples were cryoprotected 
in 30% sucrose/PBS solutions then in 30% sucrose/PBS:OCT (1:1) solutions, each overnight 
at 4C°. Samples were embedded in an OCT compound (TissuTek, Sakura) under a 
stereomicroscope and transferred on a sheet of dry ice to solidify the compound. Embedded 
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samples were cryosectioned at 15µm using a cryostat (Leica CM1850). Images were 
captured with a widefield fluorescence microscope (Nikon Eclipse E800) with prefigured 
triple-band filter settings for DAPI/FITC/TRITC, and merged with Spot Advanced Software 
(Spot Imaging) or an automated fluorescent microscope with a whole-slide scanning 
platform (TissueFAXS, TissueGnostics). Confocal images were acquired using LSM510 and 
Zen2009 software (Zeiss) with lasers and corresponding band-pass filters for DAPI (Ex.
405nm, BP420-480), GFP (Ex.488nm, BP505-530), tdTomato (Ex.543nm, BP565-595) and 
Alexa633 (Ex.633nm LP650). LSM Image Viewer and Adobe Photoshop software were 
used to capture and align images. Representative images of at least three independent 
biological samples were shown in the figures.
Flow cytometry
Femurs, tibias, iliac crests and humeri were carefully dissected and gently crushed in 5ml 
Ca2+, Mg2+-free HBSS (Sigma) with a pestle and a mortar (Coors Tek), then supernatants 
were filtered through a 70µm cell strainer (Fisher) into a 50ml tube on ice. Bone fragments 
were crushed for two additional times in 5ml HBSS and supernatants were filtered into the 
same tube. Tissue remnants were incubated with 2 Wunsch units of Liberase TM (Roche) at 
37°C for 45 minutes on a shaking incubator (Thermomixer, Eppendorf). 0.25% trypsin-
EDTA (Gibco) was added for experiments to harvest osteoblasts. Cells were mechanically 
triturated using an 18-gauge needle and a 1ml syringe (BD) and filtered into the same tube. 
Cells were pelleted, resuspended and layered over Ficoll-Paque PLUS (GE Healthcare) to 
collect low-density cell fractions. Cells were stained with anti-mouse CD45-APC, CD45-
eFlour 450, Ter119-eFlour 450, Sca1-Alexa Flour 700 (1:500, eBioscicence), PDGFRα 
(CD140a)-APC (1:250, eBioscience) or their isotype controls (1:500, eBioscience) in DPBS/
2%FBS on ice for 30 min. Flow cytometry was performed using a four-laser BD LSRII (Ex.
355/407/488/633nm) and FACSDiva, and analyzed on FlowJo (TreeStar). Representative 
plots of at least three independent biological samples were shown in the figures.
Immunohistochemisty
Cryosections were stored at −20C° freezers until use. Sections were postfixed in 4% 
paraformaldehyde for 15 minutes, blocked with 2% BSA/TBST for 30 minutes and 
incubated with rat anti-CD31 monoclonal antibody (1:100, AbD Serotec MCA2388), 
overnight at 4°C, and subsequently with Alexa Fluor 633-conjugated goat anti-rat IgG 
(1:400, Invitrogen A21087) for 3 hours at 4°C. For lipid staining, cryosections were gently 
rinsed with TBS and incubated with LipidTOX Deep Red (1:200, Invitrogen H34477) for 30 
minutes at room temperature. Sections were further incubated with DAPI (4',6-diamidino-2-
phenylindole, Invitrogen D1306) to stain nuclei. Stained samples were cover-slipped and 
mounted in a mounting medium for fluorescence imaging (Vectashield H-1000, Vector 
Labs). The edge of the cover slip was coated with commercially available transparent nail 
polish.
Cell proliferation assay
To evaluate cell proliferation, 1mg of 5-ethynyl-2’-deoxyuridine (EdU) (Invitrogen A10044) 
dissolved in PBS was administered to pregnant mice three hours before sacrificed at 
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indicated embryonic days. Click-iT Imaging Kit (Invitrogen, C10337) with Alexa Flour 647-
azide (Invitrogen A10277) was used to detect EdU in cryosections.
Colony-forming unit fibroblast (CFU-F) assay
Bone marrow cells were harvested as described in the Flow cytometry section. 106 bone 
marrow nucleated cells were plated into a 9.6cm2 glass bottom chamber slide (Lab-Tek II, 
Nunc) and cultured in MesenCult Proliferation medium for mouse cells (StemCell 
technologies) for 10 days. Cells were fixed in 4% paraformaldehyde, for 30 minutes at 4C° 
and counterstained with Wheat Germ Agglutinin Alexa Flour 488 conjugate (Invitrogen 
W11261) for 15 minutes. Representative images from at least three independent biological 
samples were shown in the figures.
Statistical Analysis
Results were represented as mean values ± S.D. Statistical evaluation was conducted using 
the Mann-Whitney’s U-test. A P-value of <0.05 was considered significant. No statistical 
method was used to predetermine sample size. Sample size was determined based on 
previous literature and our prior experience that give sufficient standard deviations of the 
mean so as not to miss a biologically important difference between groups. The experiments 
were not randomized. All the available mice of the desired genotypes were used for 
experiments. The investigators were not blinded to during experiments and outcome 
assessment. One femur from each mouse was arbitrarily chosen for histological analysis. 
Genotypes were not particularly highlighted during quantification.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Fate mapping of Col2-cre+ and Osx-cre+ cells during endochondral ossification
a–c. Fate mapping of Col2-cre+ cells was performed using Col1-GFP; Col2-cre; R26RTomato 
mice, with EdU administration prior to analysis. (a) Embryonic day 12.5 (E12.5); sharps: 
Tomato+ perichondrial cells, asterisks: Tomato+ chondrocytes. (b) E14.5; arrowheads: 
Col1+Tomato+ perichondrial cells. (c) E15.5; asterisks: Tomato+ cells in primary 
ossification center. Green: EGFP, red: tdTomato, blue: Alexa647, gray: DAPI. Scale bars: 
100µm.
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d–f. Fate mapping of Osx-cre+ cells was performed using Osx-cre∷GFP; R26RTomato mice, 
with EdU administration prior to analysis (e,f). (d) E12.5; arrows: Osx+ perichondrium. (e) 
E14.5; arrows: Osx+Col1− perichondrium, arrowheads: Osx+ prehypertrophic chondrocytes. 
(f) E15.5; asterisks: Osx+ cells in primary ossification center. Green: EGFP, red: tdTomato, 
blue: Alexa647, gray: DAPI. Scale bars: 100µm.
g. Fate mapping of Col2-cre+ cells in Runx2-deficient bone anlage at E14.5 was performed 
using Col1-GFP; Col2-cre; R26RTomato; Runx2−/− mice. Middle and right panels: dotted 
area of left panel revealing perichondrium. Arrows: Tomato+ perichondrial cells, 
arrowheads: Tomato+ chondrocytes beneath perichondrium. Green: EGFP, red: tdTomato, 
gray: DAPI and DIC (differential interference contrast). Scale bars: 100µm (left panel) and 
10µm (center and right panels).
h,j. Comparative fate mapping in postnatal day 3 (P3) bones was performed using Col1-
GFP; Col2-cre; R26RTomato (h) and Col1-GFP; Osx-cre; R26RTomato (j) mice. Green: EGFP, 
red: tdTomato, blue: DAPI. Scale bars: 500µm.
i,k. Comparative fate mapping in P3 bones was performed using Cxcl12-GFP; Col2-cre; 
R26RTomato (i) and Cxcl12-GFP; Osx-cre; R26RTomato (k) mice. Shown are diaphyseal 
endocortices and bone marrows, stained for CD31. Green: EGFP, red: tdTomato, blue: 
Alexa633, gray: DAPI. Scale bars: 50µm.
l,m. Flow cytometry analysis was performed using dissociated bone cells harvested at P3. 
CD45− fraction was gated for GFP. (l) Representative dot plots of cells from Col2-cre; 
R26RTomato mice that also carry Col1-GFP (left middle panel), Oc-GFP (right middle panel) 
or Cxcl12-GFP (rightmost panel). Leftmost panel: no GFP control. Lower panels: 
histograms of the GFP+ fraction developed for Tomato; blue lines: GFP+Tomato control 
cells. (m) Representative dot plots of cells from Osx-cre∷GFP; R26RTomato mice that also 
carry Col1-GFP (left middle panel), Oc-GFP (right middle panel) or Cxcl12-GFP (rightmost 
panel). Leftmost panel: Osx-GFP only control. Lower panels: histograms of the GFPhigh 
fraction developed for Tomato; blue lines: GFPhighTomato control cells. Upper panels; X-
axis: tdTomato, Y-axis: GFP. Lower panels; X-axis: tdTomato. n=3 mice per group. All data 
are represented as mean ± SD.
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Figure 2. Col2-creERmarks cells earlier than Osx-creER+ cells in the osteoblast lineage in fetal 
mice
a,b. Pregnant mice received 1mg tamoxifen at E11.5, and Col1-GFP; Col2-creER; 
R26RTomato mice were chased for 24 hours (a; E12.5) or 4 days (b; E15.5). Shown are distal 
halves of growth cartilages. Perichondrium is on top. Femur sections were stained for nuclei 
and CD31. Arrows: Tomato+ perichondrial cells, asterisks: Tomato+ chondrocytes, sharps: 
Tomato+ cells in primary ossification center. Green: EGFP, red: tdTomato, blue: Alexa633, 
gray: DAPI.
c.d. Lineage-tracing of embryonic Col2-creER+ and Osx-creER+ cells was performed by 
injecting 1mg tamoxifen into pregnant mice at E11.5, and Col2-creER; R26RTomato (c) or 
Osx-creER; R26RTomato (d) mice were chased until P0. Shown are femur sections with the 
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distal side on the left. Col2creER-E11.5 represents descendants of Col2-creER+ cells at 
E11.5. White indicates tdTomato.
e,f. Pregnant mice received 1mg tamoxifen at E13.5, and Col2-creER; R26RTomato mice 
were chased for 24 hours (e; E14.5) or 3 days (f; E16.5). Femur sections were stained for 
nuclei and CD31. Asterisks: Tomato+ chondrocytes and sharps: Tomato+ cells in primary 
ossification center. Red: tdTomato, blue: Alexa633, gray: DAPI.
g–j. Lineage-tracing of embryonic Col2-creER+ and Osx-creER+ cells was performed by 
injecting 1mg tamoxifen into pregnant mice at E13.5, and Col2-creER; R26RTomato (g,h) or 
Osx-creER; R26RTomato (i,j) mice were chased until indicated postnatal day (P0 or P21). 
Shown are femur sections with the distal side on the left. Col2creER-E13.5 represents 
descendants of Col2-creER+ cells at E13.5. White indicates tdTomato. Scale bars: 100µm 
(a,b,e,f) or 500µm (c,d,g–j).
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Figure 3. Col2-creER+ cells encompass early cells of the osteoblast lineage in postnatal mice
a–h. Lineage-tracing of postnatal Col2-creER+ and Osx-creER+ cells was performed by 
injecting 0.1mg tamoxifen into P3 mice. Col2-creER; R26RTomato (a–d) or Osx-creER; 
R26RTomato (e–h) mice were chased for a week (a,e), a month (b,f), a year (c,g) and 18 
months (d,h). Shown are femur sections with the distal side on the left. Col2creER-P3 
represents descendants of Col2-creER+ cells at P3. Arrowheads in (g) point to Col2creER-P3 
cells under the growth plate and beneath the perichondrium. White indicates tdTomato..
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i–l. No tamoxifen controls of Col2-creER; R26RTomato (i,j) or Osx-creER; R26RTomato (k,l) 
mice at 1 month of age (i,k) or 1 year of age (j,l) are shown. Shown are femur sections with 
the distal side on the left. White indicates tdTomato.
m. Osx-creER; R26RTomato mice received 0.1mg tamoxifen at P3 and were chased for a 
year. Shown are higher magnification views of Figure 3g. OsxcreER-P3 represents 
descendants of Osx-creER+ cells at P3. Left and right two panels show the magnified views 
of the metaphysis and diaphysis, respectively. Subpanels on the right show a single color 
view of tdTomato. Blue indicates DAPI and red and white indicate tdTomato. Scale bars: 
1mm (a–l) or 500µm (m).
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Figure 4. Col2-creER+ cells generate multiple mesenchymal lineages in postnatal growing bones
a,b. Col1-GFP; Col2-creER; R26RTomato mice received 0.1mg tamoxifen at P3 and were 
chased for 48 hours (a) or a week (b). Shown are distal halves of growth cartilages at the 
junction of growth plate and primary spongiosa. Perichondrium is on top. Femur sections 
were stained for nuclei and CD31. Asterisks: Tomato+ chondrocytes, sharps: Tomato+ 
perichondrial cells, arrows: Tomato+ cells in primary spongiosa, arrowheads: a group of 
Tomato+ cells directly under the growth plate and beneath the perichondrium. c,d. Cxcl12-
GFP; Osx-creER; R26RTomato mice received 0.1mg tamoxifen at P3 and were chased for 48 
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hours (c) or a week (d). Shown are distal halves of growth cartilages at the junction of 
growth plate and primary spongiosa. Perichondrium is on top. Femur sections were stained 
for nuclei and CD31. Arrows: Tomato+ perichondrial cells, asterisks: Tomato+ osteoblasts, 
arrowheads: GFP+Tomato+ stromal cells. e,f. Cxcl12-GFP; Col2-creER; R26RTomato (e) or 
Cxcl12-GFP; Osx-creER; R26RTomato (f) mice received 0.1mg tamoxifen at P3 and were 
chased for a month. Shown are metaphyseal spongiosa (left panel) and diaphyseal 
endocortex (right panel). Femur sections were stained for nuclei and CD31. Asterisks: 
Tomato+ osteoblasts, arrowheads: GFP+Tomato+ stromal cells. For a–f, Green: EGFP, red: 
tdTomato, blue: Alexa633, gray: DAPI. Scale bars: 100µm.
g,h. Flow cytometry analysis was performed using dissociated bone cells harvested from 
mice that received 0.1mg tamoxifen at P3 (except no tamoxifen controls) and were chased 
for indicated periods. CD45− fraction was gated for GFP. (g) Representative dot plots of 
cells from Col1-GFP; Col2-creER; R26RTomato (upper panels) and Cxcl12-GFP; Col2-
creER; R26RTomato (lower panels) mice. (h) Representative dot plots of cells from Col1-
GFP; Osx-creER; R26RTomato (upper panels) and Cxcl12-GFP; Osx-creER; R26RTomato 
(lower panels) mice. Left panels: 2 days chase, middle panels: 4 weeks chase, right panels: 
no tamoxifen controls. X-axis represents tdTomato, and Y-axis represents GFP.
i,j. Percentage of Col2creER-P3 cells (o) or OsxcreER-P3 cells (p) among Col1-GFP+ (blue 
lines) osteoblasts or Cxcl12-GFP+ (red lines) stromal cells during the chase. X-axis 
represents the duration of the chase, and Y-axis represents the percentage of Tomato+GFP+ 
cells among total GFP+ cells. Dotted lines represent no tamoxifen controls. n=3–6 mice per 
group (see Methods for precise n values). All data are represented as mean ± SD.
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Figure 5. Relationship of growth skeletal progenitor cells and adult bone marrow stromal/
mesenchymal progenitor cells
a. Colony-forming unit fibroblast (CFU-F) assay was performed using unfractionated P5 
bone marrow cells plated at a clonal density (106 cells per 9.6cm2) and cultured for 10 days. 
Cells were harvested from Col2-cre; R26RTomato (a, left panel), Osx-cre; R26RTomato (a, left 
panel) mice, Col2-creER; R26RTomato or Osx-creER; R26RTomato mice that received 0.1mg 
tamoxifen at P3. White indicates tdTomato. Insets highlight examples of Tomato+ colonies. 
Scale bars: 2mm.
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b,c. Percentage of Tomato+ colonies among total colonies (>50 cells) was enumerated. P5 
bone marrow cells from Col2-cre; R26RTomato or Osx-cre; R26RTomato mice (b), and Col2-
creER; R26RTomato or Osx-creER; R26RTomato mice that received 0.1mg tamoxifen at P3 (c) 
were subjected to CFU-F assay. n=4 mice per group, *p<0.05. All data are represented as 
mean ± SD.
d,e,h,i. Flow cytometry analysis was performed using dissociated bone cells stained for 
CD45, Ter119, PDGFRα (CD140a) and Sca1. (d) Cells were harvested from Cxcl12-GFP; 
Col2-cre; R26RTomato (left panel) or Cxcl12-GFP; Osx-cre; R26RTomato (right panel) mice at 
P14. Representative contour plots of CD45−Ter119−CD140a+Sca1+ (PαS) (d) or 
CD45−Ter119−CD140a+Sca1− (PαS−) (h) fraction of the indicated genotype. X-axis 
represents tdTomato, and Y-axis represents Cxcl12-GFP. (e,i) Percentage of Tomato+ PαS 
cells (e) and Tomato+ PαS− cells among total PαS cells. n=4 mice per group. *p<0.05. All 
data are represented as mean ± SD.
f,j. Flow cytometry analysis was performed using dissociated bone cells stained for CD45, 
Ter119, PDGFRα (CD140a) and Sca1. Representative contour plots of 
CD45−Ter119−CD140a+Sca1+ (PαS) (f) or CD45−Ter119−CD140a+Sca1− (PαS−) (j) 
fraction of Nes-GFP; Nes-creER; R26RTomato (left panels), Cxcl12-GFP; Col2-creER; 
R26RTomato (middle panels) or Cxcl12-GFP; Osx-creER; R26RTomato (right panels) mice 
that received 0.1mg tamoxifen at P3. Left subpanels show 2 days of chase and right 
subpanels show 4 weeks of chase. X-axis represents tdTomato, and Y-axis represents GFP.
g,k. Percentage of NescreER-P3 cells (purple line), Col2creER-P3 cells (red line) or OsxcreER-
P3 cells (blue line) among CD45−Ter119−CD140a+Sca1+ (PαS) (g) or 
CD45−Ter119−CD140a+Sca1− (PαS−) (k) cells during the chase was plotted. X-axis 
represents the duration of the chase, and Y-axis represents the percentage of Tomato+GFP+ 
cells among total GFP+ cells. n=3–9 mice per group (see Methods for precise n values). All 
data are represented as mean ± SD.
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Figure 6. Sox9-creER+ and Acan-creER+ cells encompass early growth skeletal progenitor cells 
in postnatal growing bones
a–f. Lineage-tracing of postnatal Sox9-creER+ and Acan-creER+ cells was performed by 
injecting 0.1mg tamoxifen into P3 mice. Sox9-creER; R26RTomato (a–c) or Acan-creER; 
R26RTomato (d–f) mice were chased for a week (a,d), a month (b,e) and 6 months (c,f). 
Shown are femur sections with the distal side on the left. Sox9creER-P3 represents 
descendants of Sox9-creER+ cells at P3, and AcancreER-P3 represents descendants of Acan-
creER+ cells at P3. White indicates tdTomato. Scale bars: 1mm.
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g,h. No tamoxifen controls of Sox9-creER; R26RTomato (g) or Acan-creER; R26RTomato (h) 
mice at 6 months of age. Shown are femur sections with the distal side on the left. White 
indicates tdTomato. Scale bars: 1mm.
i,j. Flow cytometry analysis was performed using dissociated bone cells harvested from 
mice that received 0.1mg tamoxifen at P3 (except no tamoxifen controls) and were chased 
for indicated periods. CD45− fraction was gated for GFP. (i) Representative dot plots of 
cells from Col1-GFP; Sox9-creER; R26RTomato (left panels) and Col1-GFP; Acan-creER; 
R26RTomato (right panels) mice. Left subpanels: 2 days chase, middle subpanels: 4 weeks 
chase, right subpanels: no tamoxifen controls. X-axis represents tdTomato, and Y-axis 
represents GFP. (j) Percentage of Sox9creER-P3 cells (blue bars), Col2creER-P3 cells (green 
bars) or AcancreER-P3 cells (red bars) among Col1-GFP+ osteoblasts after 2 days of chase 
(left group) or 4 weeks of chase (right group) was enumerated. n=3 mice for 2 days chase of 
Sox9creER-P3 and AcancreER-P3 cells, n=4 mice for 2 days chase of Col2creER-P3 cells, n=8 
mice for 4 weeks chase of Sox9creER-P3 cells, n=5 mice for 4 weeks chase of Col2creER-P3 
and AcancreER-P3 cells. All data are represented as mean ± SD.
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